1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global NK Cell Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 NK Cell Therapies
        1.2.3 NK Cell Directed Antibodies
    1.3 Market by Application
        1.3.1 Global NK Cell Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Cancer
        1.3.3 Gastrointestinal Diseases
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global NK Cell Therapy Market Perspective (2017-2028)
    2.2 NK Cell Therapy Growth Trends by Region
        2.2.1 NK Cell Therapy Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 NK Cell Therapy Historic Market Size by Region (2017-2022)
        2.2.3 NK Cell Therapy Forecasted Market Size by Region (2023-2028)
    2.3 NK Cell Therapy Market Dynamics
        2.3.1 NK Cell Therapy Industry Trends
        2.3.2 NK Cell Therapy Market Drivers
        2.3.3 NK Cell Therapy Market Challenges
        2.3.4 NK Cell Therapy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top NK Cell Therapy Players by Revenue
        3.1.1 Global Top NK Cell Therapy Players by Revenue (2017-2022)
        3.1.2 Global NK Cell Therapy Revenue Market Share by Players (2017-2022)
    3.2 Global NK Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by NK Cell Therapy Revenue
    3.4 Global NK Cell Therapy Market Concentration Ratio
        3.4.1 Global NK Cell Therapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by NK Cell Therapy Revenue in 2021
    3.5 NK Cell Therapy Key Players Head office and Area Served
    3.6 Key Players NK Cell Therapy Product Solution and Service
    3.7 Date of Enter into NK Cell Therapy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 NK Cell Therapy Breakdown Data by Type
    4.1 Global NK Cell Therapy Historic Market Size by Type (2017-2022)
    4.2 Global NK Cell Therapy Forecasted Market Size by Type (2023-2028)
5 NK Cell Therapy Breakdown Data by Application
    5.1 Global NK Cell Therapy Historic Market Size by Application (2017-2022)
    5.2 Global NK Cell Therapy Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America NK Cell Therapy Market Size (2017-2028)
    6.2 North America NK Cell Therapy Market Size by Type
        6.2.1 North America NK Cell Therapy Market Size by Type (2017-2022)
        6.2.2 North America NK Cell Therapy Market Size by Type (2023-2028)
        6.2.3 North America NK Cell Therapy Market Share by Type (2017-2028)
    6.3 North America NK Cell Therapy Market Size by Application
        6.3.1 North America NK Cell Therapy Market Size by Application (2017-2022)
        6.3.2 North America NK Cell Therapy Market Size by Application (2023-2028)
        6.3.3 North America NK Cell Therapy Market Share by Application (2017-2028)
    6.4 North America NK Cell Therapy Market Size by Country
        6.4.1 North America NK Cell Therapy Market Size by Country (2017-2022)
        6.4.2 North America NK Cell Therapy Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe NK Cell Therapy Market Size (2017-2028)
    7.2 Europe NK Cell Therapy Market Size by Type
        7.2.1 Europe NK Cell Therapy Market Size by Type (2017-2022)
        7.2.2 Europe NK Cell Therapy Market Size by Type (2023-2028)
        7.2.3 Europe NK Cell Therapy Market Share by Type (2017-2028)
    7.3 Europe NK Cell Therapy Market Size by Application
        7.3.1 Europe NK Cell Therapy Market Size by Application (2017-2022)
        7.3.2 Europe NK Cell Therapy Market Size by Application (2023-2028)
        7.3.3 Europe NK Cell Therapy Market Share by Application (2017-2028)
    7.4 Europe NK Cell Therapy Market Size by Country
        7.4.1 Europe NK Cell Therapy Market Size by Country (2017-2022)
        7.4.2 Europe NK Cell Therapy Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific NK Cell Therapy Market Size (2017-2028)
    8.2 Asia-Pacific NK Cell Therapy Market Size by Type
        8.2.1 Asia-Pacific NK Cell Therapy Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific NK Cell Therapy Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific NK Cell Therapy Market Share by Type (2017-2028)
    8.3 Asia-Pacific NK Cell Therapy Market Size by Application
        8.3.1 Asia-Pacific NK Cell Therapy Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific NK Cell Therapy Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific NK Cell Therapy Market Share by Application (2017-2028)
    8.4 Asia-Pacific NK Cell Therapy Market Size by Region
        8.4.1 Asia-Pacific NK Cell Therapy Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific NK Cell Therapy Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America NK Cell Therapy Market Size (2017-2028)
    9.2 Latin America NK Cell Therapy Market Size by Type
        9.2.1 Latin America NK Cell Therapy Market Size by Type (2017-2022)
        9.2.2 Latin America NK Cell Therapy Market Size by Type (2023-2028)
        9.2.3 Latin America NK Cell Therapy Market Share by Type (2017-2028)
    9.3 Latin America NK Cell Therapy Market Size by Application
        9.3.1 Latin America NK Cell Therapy Market Size by Application (2017-2022)
        9.3.2 Latin America NK Cell Therapy Market Size by Application (2023-2028)
        9.3.3 Latin America NK Cell Therapy Market Share by Application (2017-2028)
    9.4 Latin America NK Cell Therapy Market Size by Country
        9.4.1 Latin America NK Cell Therapy Market Size by Country (2017-2022)
        9.4.2 Latin America NK Cell Therapy Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa NK Cell Therapy Market Size (2017-2028)
    10.2 Middle East & Africa NK Cell Therapy Market Size by Type
        10.2.1 Middle East & Africa NK Cell Therapy Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa NK Cell Therapy Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa NK Cell Therapy Market Share by Type (2017-2028)
    10.3 Middle East & Africa NK Cell Therapy Market Size by Application
        10.3.1 Middle East & Africa NK Cell Therapy Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa NK Cell Therapy Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa NK Cell Therapy Market Share by Application (2017-2028)
    10.4 Middle East & Africa NK Cell Therapy Market Size by Country
        10.4.1 Middle East & Africa NK Cell Therapy Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa NK Cell Therapy Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Nektar Therapeutics
        11.1.1 Nektar Therapeutics Company Details
        11.1.2 Nektar Therapeutics Business Overview
        11.1.3 Nektar Therapeutics NK Cell Therapy Introduction
        11.1.4 Nektar Therapeutics Revenue in NK Cell Therapy Business (2017-2022)
        11.1.5 Nektar Therapeutics Recent Developments
    11.2 Innate Pharma SA
        11.2.1 Innate Pharma SA Company Details
        11.2.2 Innate Pharma SA Business Overview
        11.2.3 Innate Pharma SA NK Cell Therapy Introduction
        11.2.4 Innate Pharma SA Revenue in NK Cell Therapy Business (2017-2022)
        11.2.5 Innate Pharma SA Recent Developments
    11.3 Affimed
        11.3.1 Affimed Company Details
        11.3.2 Affimed Business Overview
        11.3.3 Affimed NK Cell Therapy Introduction
        11.3.4 Affimed Revenue in NK Cell Therapy Business (2017-2022)
        11.3.5 Affimed Recent Developments
    11.4 Chipscreen Biosciences
        11.4.1 Chipscreen Biosciences Company Details
        11.4.2 Chipscreen Biosciences Business Overview
        11.4.3 Chipscreen Biosciences NK Cell Therapy Introduction
        11.4.4 Chipscreen Biosciences Revenue in NK Cell Therapy Business (2017-2022)
        11.4.5 Chipscreen Biosciences Recent Developments
    11.5 Fate Therapeutics
        11.5.1 Fate Therapeutics Company Details
        11.5.2 Fate Therapeutics Business Overview
        11.5.3 Fate Therapeutics NK Cell Therapy Introduction
        11.5.4 Fate Therapeutics Revenue in NK Cell Therapy Business (2017-2022)
        11.5.5 Fate Therapeutics Recent Developments
    11.6 Glycostem Therapeutics
        11.6.1 Glycostem Therapeutics Company Details
        11.6.2 Glycostem Therapeutics Business Overview
        11.6.3 Glycostem Therapeutics NK Cell Therapy Introduction
        11.6.4 Glycostem Therapeutics Revenue in NK Cell Therapy Business (2017-2022)
        11.6.5 Glycostem Therapeutics Recent Developments
    11.7 Dragonfly Therapeutics
        11.7.1 Dragonfly Therapeutics Company Details
        11.7.2 Dragonfly Therapeutics Business Overview
        11.7.3 Dragonfly Therapeutics NK Cell Therapy Introduction
        11.7.4 Dragonfly Therapeutics Revenue in NK Cell Therapy Business (2017-2022)
        11.7.5 Dragonfly Therapeutics Recent Developments
    11.8 Kiadis Pharma
        11.8.1 Kiadis Pharma Company Details
        11.8.2 Kiadis Pharma Business Overview
        11.8.3 Kiadis Pharma NK Cell Therapy Introduction
        11.8.4 Kiadis Pharma Revenue in NK Cell Therapy Business (2017-2022)
        11.8.5 Kiadis Pharma Recent Developments
    11.9 NantWorks
        11.9.1 NantWorks Company Details
        11.9.2 NantWorks Business Overview
        11.9.3 NantWorks NK Cell Therapy Introduction
        11.9.4 NantWorks Revenue in NK Cell Therapy Business (2017-2022)
        11.9.5 NantWorks Recent Developments
    11.10 Nkarta Therapeutics
        11.10.1 Nkarta Therapeutics Company Details
        11.10.2 Nkarta Therapeutics Business Overview
        11.10.3 Nkarta Therapeutics NK Cell Therapy Introduction
        11.10.4 Nkarta Therapeutics Revenue in NK Cell Therapy Business (2017-2022)
        11.10.5 Nkarta Therapeutics Recent Developments
    11.11 Fortress Biotech
        11.11.1 Fortress Biotech Company Details
        11.11.2 Fortress Biotech Business Overview
        11.11.3 Fortress Biotech NK Cell Therapy Introduction
        11.11.4 Fortress Biotech Revenue in NK Cell Therapy Business (2017-2022)
        11.11.5 Fortress Biotech Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global NK Cell Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of NK Cell Therapies
    Table 3. Key Players of NK Cell Directed Antibodies
    Table 4. Global NK Cell Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global NK Cell Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global NK Cell Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global NK Cell Therapy Market Share by Region (2017-2022)
    Table 8. Global NK Cell Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global NK Cell Therapy Market Share by Region (2023-2028)
    Table 10. NK Cell Therapy Market Trends
    Table 11. NK Cell Therapy Market Drivers
    Table 12. NK Cell Therapy Market Challenges
    Table 13. NK Cell Therapy Market Restraints
    Table 14. Global NK Cell Therapy Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global NK Cell Therapy Revenue Share by Players (2017-2022)
    Table 16. Global Top NK Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NK Cell Therapy as of 2021)
    Table 17. Ranking of Global Top NK Cell Therapy Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by NK Cell Therapy Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players NK Cell Therapy Product Solution and Service
    Table 21. Date of Enter into NK Cell Therapy Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global NK Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global NK Cell Therapy Revenue Market Share by Type (2017-2022)
    Table 25. Global NK Cell Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global NK Cell Therapy Revenue Market Share by Type (2023-2028)
    Table 27. Global NK Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global NK Cell Therapy Revenue Share by Application (2017-2022)
    Table 29. Global NK Cell Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global NK Cell Therapy Revenue Share by Application (2023-2028)
    Table 31. North America NK Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America NK Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America NK Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America NK Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America NK Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America NK Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe NK Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe NK Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe NK Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe NK Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe NK Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe NK Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific NK Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific NK Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific NK Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific NK Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific NK Cell Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific NK Cell Therapy Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America NK Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America NK Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America NK Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America NK Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America NK Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America NK Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa NK Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa NK Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa NK Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa NK Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa NK Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa NK Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Nektar Therapeutics Company Details
    Table 62. Nektar Therapeutics Business Overview
    Table 63. Nektar Therapeutics NK Cell Therapy Product
    Table 64. Nektar Therapeutics Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million)
    Table 65. Nektar Therapeutics Recent Developments
    Table 66. Innate Pharma SA Company Details
    Table 67. Innate Pharma SA Business Overview
    Table 68. Innate Pharma SA NK Cell Therapy Product
    Table 69. Innate Pharma SA Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million)
    Table 70. Innate Pharma SA Recent Developments
    Table 71. Affimed Company Details
    Table 72. Affimed Business Overview
    Table 73. Affimed NK Cell Therapy Product
    Table 74. Affimed Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million)
    Table 75. Affimed Recent Developments
    Table 76. Chipscreen Biosciences Company Details
    Table 77. Chipscreen Biosciences Business Overview
    Table 78. Chipscreen Biosciences NK Cell Therapy Product
    Table 79. Chipscreen Biosciences Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million)
    Table 80. Chipscreen Biosciences Recent Developments
    Table 81. Fate Therapeutics Company Details
    Table 82. Fate Therapeutics Business Overview
    Table 83. Fate Therapeutics NK Cell Therapy Product
    Table 84. Fate Therapeutics Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million)
    Table 85. Fate Therapeutics Recent Developments
    Table 86. Glycostem Therapeutics Company Details
    Table 87. Glycostem Therapeutics Business Overview
    Table 88. Glycostem Therapeutics NK Cell Therapy Product
    Table 89. Glycostem Therapeutics Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million)
    Table 90. Glycostem Therapeutics Recent Developments
    Table 91. Dragonfly Therapeutics Company Details
    Table 92. Dragonfly Therapeutics Business Overview
    Table 93. Dragonfly Therapeutics NK Cell Therapy Product
    Table 94. Dragonfly Therapeutics Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million)
    Table 95. Dragonfly Therapeutics Recent Developments
    Table 96. Kiadis Pharma Company Details
    Table 97. Kiadis Pharma Business Overview
    Table 98. Kiadis Pharma NK Cell Therapy Product
    Table 99. Kiadis Pharma Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million)
    Table 100. Kiadis Pharma Recent Developments
    Table 101. NantWorks Company Details
    Table 102. NantWorks Business Overview
    Table 103. NantWorks NK Cell Therapy Product
    Table 104. NantWorks Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million)
    Table 105. NantWorks Recent Developments
    Table 106. Nkarta Therapeutics Company Details
    Table 107. Nkarta Therapeutics Business Overview
    Table 108. Nkarta Therapeutics NK Cell Therapy Product
    Table 109. Nkarta Therapeutics Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million)
    Table 110. Nkarta Therapeutics Recent Developments
    Table 111. Fortress Biotech Company Details
    Table 112. Fortress Biotech Business Overview
    Table 113. Fortress Biotech NK Cell Therapy Product
    Table 114. Fortress Biotech Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million)
    Table 115. Fortress Biotech Recent Developments
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global NK Cell Therapy Market Share by Type: 2021 VS 2028
    Figure 2. NK Cell Therapies Features
    Figure 3. NK Cell Directed Antibodies Features
    Figure 4. Global NK Cell Therapy Market Share by Application: 2021 VS 2028
    Figure 5. Cancer Case Studies
    Figure 6. Gastrointestinal Diseases Case Studies
    Figure 7. Others Case Studies
    Figure 8. NK Cell Therapy Report Years Considered
    Figure 9. Global NK Cell Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global NK Cell Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global NK Cell Therapy Market Share by Region: 2021 VS 2028
    Figure 12. Global NK Cell Therapy Market Share by Players in 2021
    Figure 13. Global Top NK Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NK Cell Therapy as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by NK Cell Therapy Revenue in 2021
    Figure 15. North America NK Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America NK Cell Therapy Market Size Market Share by Type (2017-2028)
    Figure 17. North America NK Cell Therapy Market Size Market Share by Application (2017-2028)
    Figure 18. North America NK Cell Therapy Market Size Share by Country (2017-2028)
    Figure 19. United States NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe NK Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe NK Cell Therapy Market Size Market Share by Type (2017-2028)
    Figure 23. Europe NK Cell Therapy Market Size Market Share by Application (2017-2028)
    Figure 24. Europe NK Cell Therapy Market Size Share by Country (2017-2028)
    Figure 25. Germany NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific NK Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific NK Cell Therapy Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific NK Cell Therapy Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific NK Cell Therapy Market Size Share by Region (2017-2028)
    Figure 35. China NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America NK Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America NK Cell Therapy Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America NK Cell Therapy Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America NK Cell Therapy Market Size Share by Country (2017-2028)
    Figure 45. Mexico NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa NK Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa NK Cell Therapy Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa NK Cell Therapy Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa NK Cell Therapy Market Size Share by Country (2017-2028)
    Figure 51. Turkey NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Nektar Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2017-2022)
    Figure 55. Innate Pharma SA Revenue Growth Rate in NK Cell Therapy Business (2017-2022)
    Figure 56. Affimed Revenue Growth Rate in NK Cell Therapy Business (2017-2022)
    Figure 57. Chipscreen Biosciences Revenue Growth Rate in NK Cell Therapy Business (2017-2022)
    Figure 58. Fate Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2017-2022)
    Figure 59. Glycostem Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2017-2022)
    Figure 60. Dragonfly Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2017-2022)
    Figure 61. Kiadis Pharma Revenue Growth Rate in NK Cell Therapy Business (2017-2022)
    Figure 62. NantWorks Revenue Growth Rate in NK Cell Therapy Business (2017-2022)
    Figure 63. Nkarta Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2017-2022)
    Figure 64. Fortress Biotech Revenue Growth Rate in NK Cell Therapy Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed